Real-World Experience with TRK Inhibitors in Patients with Lung and Colon Cancers

Ezra Cohen, MD, FRCPSC, FASCO; Mary Jo Fidler, MD; Arturo Loaiza-Bonilla, MD, MSEd, FACP

Video Categories: NTRK Gene Fusions

Dr Mary Fidler of Rush University Medical Center, Chicago, IL, and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, describe their practical experiences with TRK inhibitors in patients with lung cancer and colorectal cancer.

January 20, 2016

Making the Case for Combination Therapies

Dr Wainberg and Dr Gerson review why providers are using combination therapies and the eventual goal of investigators to hit specific targeted cells.

January 10, 2019

Is Immunotherapy Appropriate Here?

Dr Morganna Freeman on the challenge of deciding when to treat a patient with immunotherapy.